PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Short Interest Update
PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 33,300 shares, a decrease of 17.4% from the October 15th total of 40,300 shares. Based on an average trading volume of 20,600 shares, […]
More Stories
Iran Offered Better Deal ‘10 Minutes’ After US Canceled Pakistan Meeting, Trump Says
By Jacki Thrapp The Iranian regime offered the United States a “much better” peace deal within 10 minutes of President...
Iran Delegation Leaves Pakistan Without US Talks as Trump Cancels Envoy Visit
By Tom Ozimek Iranian Foreign Minister Abbas Araghchi left Pakistan for Oman on Saturday without meeting U.S. negotiators. Araghchi met...
SBA Refers 562,000 Suspected Fraudulent Loans Worth $22.2 Billion to Treasury
By Naveen Athrappully The Small Business Administration (SBA) has referred 562,000 loans suspected to be fraudulent to the Treasury Department...
US Exports of Crude and Petroleum Products Hit Record Highs
By Jacki Thrapp America’s energy exports have hit record highs as the world navigates the uncertainty surrounding oil and gas...
New Listings Tick Up 3 Percent as Mortgage Rates Continue to Slide
By Rob Sabo New home listings are on the rise across the United States, potentially spurred by hopes of falling...
US, EU Sign Preliminary Partnership Deal on Critical Minerals
By Owen Evans The United States and the European Union signed a memorandum of understanding on April 24 for a...